Concepedia

Karen McDaid

KM

4

Publications

1.1K

Citations

4

H-Index

2011

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Karen McDaid is an author at AstraZeneca (United Kingdom) specializing in tumor biology, cancer biology, and immunology.

Top concepts

Publications per year

2011–2016

4

Publications

4

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

Colin W. Steele, Saadia A. Karim, Joshua D.G. Leach et al. · Cancer Cell · 2016 · 819 citations · Full text

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy

Neil R. Smith, Dawn Baker, Matthew R. Farren et al. · Clinical Cancer Research · 2013 · 134 citations · Full text

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

Catherine A. Eberlein, Jane Kendrew, Karen McDaid et al. · Oncogene · 2012 · 86 citations

, , +9

An Antibody Targeted to VEGFR-2 Ig Domains 4-7 Inhibits VEGFR-2 Activation and VEGFR-2–Dependent Angiogenesis without Affecting Ligand Binding

Jane Kendrew, Cath Eberlein, Brad Hedberg et al. · Molecular Cancer Therapeutics · 2011 · 33 citations

, , +16

Rows per page

1–4 of 4